Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Influence of Regular Exercise and Detraining on Metabolic and Emotional Parameters in Diabetic and Hypertensive Individuals
| Verified date | March 2015 |
| Source | University of Campinas, Brazil |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Brazil: Ministry of Health |
| Study type | Interventional |
This quasi-experimental study aim to evaluate the effect of moderate aerobic exercise on glucose and lipid metabolism as well as the scales of anxiety and depression and levels of salivary cortisol in women with type 2 diabetes.
| Status | Completed |
| Enrollment | 12 |
| Est. completion date | June 2008 |
| Est. primary completion date | March 2008 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 40 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - having normal physical examinations, - no participation in regular, moderate or intensive exercise for at least 6 months before the study and - not be following a diet Exclusion Criteria: - the use of insulin and beta-blocker medications and - the functional inability to perform exercise |
Intervention Model: Single Group Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of Campinas, Brazil |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Salivary cortisol | After practicing the exercise for 3 months, patients were submitted to a new saliva collection for the salivary cortisol measure. | 3 months | No |
| Other | Hospital Anxiety and Depression scale (HADS) | After 3 months of the physical exercise, the HADS was evaluated. | 3 months | No |
| Primary | Glucose levels | After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Glucose test. | 3 months | No |
| Secondary | Systolic and Diastolic blood pressure | Change in Systolic and Diastolic blood pressure were evaluated before and after physical exercise, during 3 months. | 3 months | No |
| Secondary | Heart Rate measurement | Change in heart rate was evaluated before, during and after physical exercise, during 3 months. | 3 months | No |
| Secondary | Glycated hemoglobin levels | After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Glycated hemoglobin test. | 3 months | No |
| Secondary | Proteinuria levels | After practicing the exercise for 3 months, patients were submitted to a new collection of blood for proteinuria test. | 3 months | No |
| Secondary | Triglycerides levels | After practicing the exercise for 3 months, patients were submitted to a new collection of blood for triglycerides test. | 3 months | No |
| Secondary | High Density Level (HDL) Cholesterol levels | After practicing the exercise for 3 months, patients were submitted to a new collection of blood for High Density Level Cholesterol test. | 3 months | No |
| Secondary | Low Density Level (LDL) Cholesterol levels | After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Low Density Level Cholesterol test. | 3 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |